Literature DB >> 1380372

Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.

R G Bogle1, S Moncada, J D Pearson, G E Mann.   

Abstract

The effects of inhibitors of nitric oxide (NO) synthase and other cationic amino acids on unidirectional L-arginine transport were studied in porcine aortic endothelial cells cultured in microwell plates or perfused in microcarrier columns. L-Homoarginine, L-lysine and L-ornithine inhibited transport of L-arginine. The NO synthase inhibitors NG-monomethyl-L-arginine and NG-iminoethyl-L-ornithine also reduced L-arginine uptake, whereas NG-nitro-L-arginine and its methyl-ester had no inhibitory effect. The ability to modulate selectively endothelial cell L-arginine transport or NO synthase activity will allow further characterization of the arginine transporter and its role in regulating NO biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380372      PMCID: PMC1908727          DOI: 10.1111/j.1476-5381.1992.tb09053.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase.

Authors:  D S Bredt; P M Hwang; C E Glatt; C Lowenstein; R R Reed; S H Snyder
Journal:  Nature       Date:  1991-06-27       Impact factor: 49.962

Review 2.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

3.  Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter.

Authors:  H Wang; M P Kavanaugh; R A North; D Kabat
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

4.  Endothelial nitric oxide generating enzyme(s) in the bovine aorta: subcellular location and metabolic characterization.

Authors:  K M Boje; H L Fung
Journal:  J Pharmacol Exp Ther       Date:  1990-04       Impact factor: 4.030

5.  Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.

Authors:  T B McCall; M Feelisch; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

6.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

7.  Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells.

Authors:  U Förstermann; J S Pollock; H H Schmidt; M Heller; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

8.  Transport of cationic amino acids by the mouse ecotropic retrovirus receptor.

Authors:  J W Kim; E I Closs; L M Albritton; J M Cunningham
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

9.  Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells.

Authors:  R G Bogle; S B Coade; S Moncada; J D Pearson; G E Mann
Journal:  Biochem Biophys Res Commun       Date:  1991-10-31       Impact factor: 3.575

10.  L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.

Authors:  P K Moore; O A al-Swayeh; N W Chong; R A Evans; A Gibson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

  10 in total
  44 in total

Review 1.  Nitric oxide and the pancreas: morphological base and role in the control of the exocrine pancreatic secretion.

Authors:  M D Yago; M Mañas; Z Ember; J Singh
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells.

Authors:  S Xiao; L Wagner; J Mahaney; C Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2001-06

3.  Electrogenic arginine transport mediates stimulus-secretion coupling in mouse pancreatic beta-cells.

Authors:  P A Smith; H Sakura; B Coles; N Gummerson; P Proks; F M Ashcroft
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

4.  Oral supplementation with L-homoarginine in young volunteers.

Authors:  Dorothee Atzler; Mirjam Schönhoff; Kathrin Cordts; Imke Ortland; Julia Hoppe; Friedhelm C Hummel; Christian Gerloff; Ulrich Jaehde; Annika Jagodzinski; Rainer H Böger; Chi-Un Choe; Edzard Schwedhelm
Journal:  Br J Clin Pharmacol       Date:  2016-09-20       Impact factor: 4.335

5.  Arginase II inhibition prevents nitrate tolerance.

Authors:  S M L Khong; K L Andrews; N N Huynh; K Venardos; A Aprico; D L Michell; M Zarei; K T Moe; G J Dusting; D M Kaye; J P F Chin-Dusting
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

6.  The effects of exogenous amino acids on the relaxant responses of pig urethral smooth muscle evoked by stimulation of the inhibitory nitrergic nerves.

Authors:  N Tugba Durlu; Alison F Brading
Journal:  Pflugers Arch       Date:  2004-10-05       Impact factor: 3.657

7.  Differential effects of lumenal L-arginine and NG-nitro L-arginine on blood flow and water fluxes in rat ileum.

Authors:  D Mailman
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Regulation of baseline vascular resistance in the canine diaphragm by nitric oxide.

Authors:  M E Ward; S N Hussain
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

9.  Alterations of insulin response to different beta cell secretagogues and pancreatic vascular resistance induced by N omega-nitro-L-arginine methyl ester.

Authors:  R Gross; M Roye; M Manteghetti; D Hillaire-Buys; G Ribes
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.

Authors:  G J Southan; B Zingarelli; M O'Connor; A L Salzman; C Szabó
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.